DENVER, April 16, 2015 — A new study has found that high levels of the antioxidant-rich acai berry significantly improves outcomes for women undergoing vitro fertilization IVF. The Colorado Center for Reproductive Medicine offered CCRM Acai, a natural antioxidant supplement, to all qualifying participants as a part of clinical research study, which aimed to improve ovarian function for women with a history of failed implantation, prior to infertility treatment. Eighty-one percent of the study participants achieved ongoing clinical pregnancies.
OvaHealth contains a very high level of natural anti-oxidant activity measured by biochemical analysis making it a more powerful supplement to support ovarian function.
There were 42 participants in the study (median age 37) and all participants had at least one previous failed IVF cycle. All participants took the CCRM Acai supplement for 8-12 weeks and underwent a blastocyst comprehensive chromosome screening (CCS) cycle. The outcomes of the study include:
- 81 percent ongoing clinical pregnancy rate. The national average is 37.8 percent for a 37-year-old.
- Mean number of eggs retrieved from previous failed cycle 15.8 with 8.1 fertilized.
- Mean number of eggs retrieved after using OvaHealth 20.6 with 11.5 fertilized (a statistically significant difference).
The CCRM Acai study is currently ongoing and CCRM is offering the supplement free of charge to all qualifying patients. Patients must meet all of the requirements and be committed to participation in the IVF program at CCRM, including:
- At least one previous failed IVF cycle at CCRM or elsewhere
- Maternal age
- Sufficient sperm for ICSI
“We are always looking for ways to improve a couple’s chances of conception,” says William Schoolcraft, M.D., medical director of CCRM. “The results of this study are extremely encouraging and we’re excited to offer the CCRM Acai supplement to our patients to help them have the best outcome possible.”